David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Consumer Discretionary | 9.92% |
| 3 | Healthcare | 7.34% |
| 4 | Financials | 7.06% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Rocket Pharmaceuticals
RCKT
$402M
| $5.54M | 0.01% |
185,434
-14,584
| -7% | -$531K |
|
1877
Alto Ingredients
ALTO
$316M
| $5.54M | 0.01% |
1,120,890
+142,333
| +15% | +$717K |
|
1878
RLJ Lodging Trust
RLJ
$1.75B
| $5.54M | 0.01% |
372,466
+235,193
| +171% | +$3.38M |
|
1879
PUT
Ally Financial
ALLY
$12.9B
| $5.53M | 0.01% |
108,400
-9,700
| -8% | -$502K |
|
|
GACQ
1880
DELISTED
Global Consumer Acquisition Corp. Common Stock
GACQ
| $5.53M | 0.01% |
+560,000
| New | +$5.48M |
|
1881
CALL
Sony
SONY
$141B
| $5.53M | 0.01% |
250,000
| – | – |
|
1882
Public Service Enterprise Group
PEG
$36.9B
| $5.53M | 0.01% |
90,724
-48,003
| -35% | -$3M |
|
|
COVA
1883
DELISTED
COVA Acquisition Corp. Class A Ordinary Share
COVA
| $5.5M | 0.01% |
566,122
+238,174
| +73% | +$2.31M |
|
1884
Home BancShares
HOMB
$5.97B
| $5.49M | 0.01% |
233,411
+212,133
| +997% | +$4.71M |
|
|
LVRA
1885
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
| $5.49M | 0.01% |
562,127
+362,127
| +181% | +$3.51M |
|
|
SNV
1886
DELISTED
Synovus
SNV
| $5.48M | ﹤0.01% |
124,905
+84,620
| +210% | +$3.58M |
|
|
CHPM
1887
DELISTED
CHP Merger Corp. Class A Common Stock
CHPM
| $5.47M | ﹤0.01% |
546,237
+358,212
| +191% | +$3.58M |
|
1888
PUT
Viatris
VTRS
$19.4B
| $5.47M | ﹤0.01% |
403,708
+38,800
| +11% | +$551K |
|
|
MIT
1889
DELISTED
Mason Industrial Technology, Inc.
MIT
| $5.46M | ﹤0.01% |
560,050
+455,733
| +437% | +$4.42M |
|
|
SPWR
1890
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $5.44M | ﹤0.01% |
240,000
-1,400
| -0.6% | -$32.7K |
|
|
Y
1891
DELISTED
Alleghany Corp
Y
| $5.44M | ﹤0.01% |
8,707
+2,221
| +34% | +$1.47M |
|
1892
Lear
LEA
$8.28B
| $5.43M | ﹤0.01% |
34,720
+26,724
| +334% | +$4.37M |
|
1893
PUT
NewMarket
NEU
$8.51B
| $5.42M | ﹤0.01% |
16,000
+2,800
| +21% | +$918K |
|
1894
Universal Display
OLED
$3.99B
| $5.42M | ﹤0.01% |
31,688
+16,330
| +106% | +$3.38M |
|
1895
Editas Medicine
EDIT
$488M
| $5.41M | ﹤0.01% |
131,747
+10,582
| +9% | +$580K |
|
1896
CEL-SCI Corp
CVM
$28.3M
| $5.41M | ﹤0.01% |
16,403
-15,384
| -48% | -$4.49M |
|
|
DEA
1897
Easterly Government Properties
DEA
$1.17B
| $5.41M | ﹤0.01% |
104,690
+18,219
| +21% | +$985K |
|
1898
HubSpot
HUBS
$11.8B
| $5.41M | ﹤0.01% |
7,995
-47,219
| -86% | -$30.4M |
|
|
NPKI
1899
NPK International
NPKI
$1.12B
| $5.4M | ﹤0.01% |
1,636,724
-460,557
| -22% | -$1.3M |
|
|
SCOB
1900
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
| $5.4M | ﹤0.01% |
553,810
+195,207
| +54% | +$1.89M |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.